Translational Development Acquisition (TDACW) Notes Payables (2023 - 2026)
Translational Development Acquisition's (TDACW) quarterly Notes Payables came in at $1.1 million in Q2 2026, up 120.0% quarter-over-quarter from $500000.0 in Q1 2026.
Powered by 
Analysis
Translational Development Acquisition (TDACW) Notes Payables (2023 - 2026) Analysis & Trends
Translational Development Acquisition (TDACW) has reported Notes Payables for 3 consecutive years, with $1.1 million the latest figure, recorded in Q2 2026.
- For the quarter ending Q2 2026, Notes Payables changed N/A year-over-year to $1.1 million; the trailing twelve-month figure through Jun 2026 stood at $1.1 million (changed N/A YoY), and the FY2025 full-year result was $200000.0, changed N/A from the prior year.
- Notes Payables climbed to $1.1 million in Q2 2026 per TDACW's latest filing, from $500000.0 in the prior quarter.
- Across five years, Notes Payables topped out at $1.1 million in Q2 2026 and bottomed at $100000.0 in Q3 2025.
- Historically, Notes Payables has averaged $449500.0 across 3 years, with a median of $347500.0 in 2023.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Evercore | 11.52 Bn | 9.43 Bn | 975.67 Mn |
| 2 | Jefferies Financial | 11.24 Bn | -4.17 Bn | 3.09 Bn |
| 3 | Houlihan Lokey | 9.53 Bn | 8.45 Bn | - |
| 4 | Cluster Group Holdings | 8.00 Bn | 8.00 Bn | - |
| 5 | PJT Partners | 6.94 Bn | 6.99 Bn | 481.98 Mn |
| 6 | Moelis | 6.06 Bn | 5.99 Bn | - |
| 7 | Piper Sandler Companies | 5.20 Bn | 5.09 Bn | - |
| 8 | Lazard | 4.97 Bn | 3.99 Bn | - |
| 9 | BRBI BR Partners | 3.44 Bn | 3.32 Bn | 16.77 Mn |
| 10 | Translational Development Acquisition | 52.67 Mn | 52.58 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 1.10 Mn |
| Mar 31, 2026 | 500,000.00 |
| Dec 31, 2025 | 200,000.00 |
| Sep 30, 2025 | 100,000.00 |
| Dec 31, 2023 | 347,500.00 |